Bank of New York Mellon Corp lessened its stake in shares of Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) by 1.9% during the 1st quarter, HoldingsChannel reports. The firm owned 149,405 shares of the technology company’s stock after selling 2,833 shares during the quarter. Bank of New York Mellon Corp’s holdings in Celestica were worth $42,084,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of Celestica by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 4,811,695 shares of the technology company’s stock worth $1,423,333,000 after buying an additional 73,022 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Celestica by 24.8% in the 4th quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company’s stock valued at $1,187,650,000 after buying an additional 798,782 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Celestica by 5,806,149.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company’s stock worth $1,081,323,000 after acquiring an additional 3,657,874 shares during the period. Franklin Resources Inc. raised its holdings in Celestica by 18.6% in the 4th quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company’s stock worth $673,471,000 after acquiring an additional 356,797 shares during the period. Finally, Cibc World Market Inc. lifted its position in Celestica by 30.6% during the 4th quarter. Cibc World Market Inc. now owns 2,265,680 shares of the technology company’s stock worth $670,279,000 after acquiring an additional 530,535 shares during the last quarter. Institutional investors own 67.38% of the company’s stock.
Celestica Price Performance
Shares of NYSE:CLS opened at $305.05 on Friday. Celestica, Inc. has a 1-year low of $164.52 and a 1-year high of $474.02. The firm has a market capitalization of $35.07 billion, a PE ratio of 36.89, a PEG ratio of 0.77 and a beta of 2.05. The business’s 50 day moving average is $362.06 and its 200-day moving average is $332.23. The company has a current ratio of 1.26, a quick ratio of 0.73 and a debt-to-equity ratio of 0.36.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on CLS shares. Royal Bank Of Canada upped their price target on shares of Celestica from $400.00 to $440.00 and gave the company an “outperform” rating in a report on Wednesday, April 29th. TD Securities raised Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective for the company in a research report on Wednesday, April 29th. Canadian Imperial Bank of Commerce restated an “outperform” rating and set a $480.00 target price on shares of Celestica in a research note on Wednesday, April 29th. Bank of America lifted their price target on Celestica from $400.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Finally, TD Cowen upgraded Celestica from a “hold” rating to a “buy” rating and upped their price target for the stock from $350.00 to $430.00 in a report on Wednesday, April 29th. Two research analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Celestica has an average rating of “Buy” and a consensus target price of $427.42.
Read Our Latest Stock Report on CLS
Insider Transactions at Celestica
In related news, CEO Robert Mionis sold 66,056 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $400.06, for a total value of $26,426,363.36. Following the sale, the chief executive officer owned 134,328 shares of the company’s stock, valued at $53,739,259.68. The trade was a 32.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Michael Max Wilson sold 4,168 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the transaction, the director owned 24,718 shares of the company’s stock, valued at approximately $8,238,756.58. This represents a 14.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 161,168 shares of company stock valued at $63,190,485. Company insiders own 1.10% of the company’s stock.
Celestica Profile
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Featured Articles
- Five stocks we like better than Celestica
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
